Introduction to Jan 09 2026 This Week In Cardiology
Exploring Jan 09 2026 This Week In Cardiology reveals several interesting facts. The limits of knowing coronary artery disease anatomy, fish oil and AF risk, a new drug for PSVT, and maybe I was wrong about a ...
Jan 09 2026 This Week In Cardiology Comprehensive Overview
A life-long treatment for high LDL, a VESALIUS subanalysis, tirzepatide beats semaglutide again, arrhythmia burden in DAPT back in the news, a practice-changing trial in VTE therapy, new knowledge in sudden Some great listener feedback, one of the best studies of the year in atrial fibrillation and heart failure, imaging to exclude left atrial ...
EVOLUT Low Risk data, a provocative meta-analysis, DNR orders, targeted hypothermia, good news in HFpEF evidence, and ...
Summary & Highlights for Jan 09 2026 This Week In Cardiology
- Listener feedback, the value of procedural volume for TAVR and MTEER, ventricular arrhythmia in older athletes, and the ...
- Listener feedback, huge news in the rapidly expanding world of PFA AF Ablation, obesity, and a beautiful trial studying an ...
- Listener feedback from the DanGer Shock investigators, complete vs staged revascularization, polygenic risk scores, and quality ...
- Listener feedback on valvular heart disease, statins and frailty, left atrial posterior wall ablation fails again, interpreting medical ...
- Time to quadruple therapy, the disappointing AVANT GUARD trial, PFA risks, the TREAT-PVC trial, and NSTEMI care in the frail ...
Stay tuned for more updates related to Jan 09 2026 This Week In Cardiology.